• Home
  • Stocks
  • Sun Pharma Advanced Research Company Fundamental Analysis
  • Sun Pharma Advanced Research Company Fundamental Analysis

Sun Pharma Advanced Research Company fundamental analysis

SPARC

MiscellaneousMid

132.1

3.10 (-2.29%)
Last updated on 13 Feb, 2026 | 15:41 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Sun Pharma Advanced Research Company Fundamentals

P/E Ratio

0

P/B Ratio

-10.08

Div. Yield

0

Sector P/E

30.23

Sector P/B

3.11

Sec. Div. Yield

1.15

Sun Pharma Advanced Research Company Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 30.23. Its P/B Ratio stands at -10.08, while the sector’s is 3.11. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 1.15%.

Sun Pharma Advanced Research Company Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Sun Pharma Advanced Research Company reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.